Metrohm Introduces OMNIS NIRS: Expanding Capabilities in Near-Infrared Spectroscopy
April 10, 2024
Metrohm is proud to announce the expansion of its OMNIS platform with the addition of near-infrared spectroscopy (NIRS) capabilities. The new OMNIS NIRS enhances the platform's versatility, enabling comprehensive chemical analysis through a single system. The introduction of OMNIS NIRS brings three specialized configurations to cater to different sample types: OMNIS NIRS Liquid for liquid [...]
Nanalysis Scientific Corp. Announces Director Resignation
April 10, 2024
CALGARY, AB - Nanalysis Scientific Corp. ("Nanalysis" or the "Company", (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) announces that Kham Lin has resigned as a director of the Company effective April 9, 2024, and the Board of Directors has accepted his resignation. The Company would like to thank Mr. Lin for his contributions throughout his tenure as director of the [...]
April 10, 2024
CINCINNATI, OHIO – The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, has announced the launch of a comprehensive menu of glycerol-free NGS enzymes for use in all steps of a Next Generation Sequencing (“NGS”) workflow. With this latest release, Meridian establishes itself as [...]
April 10, 2024
LOWER GWYNEDD, Pa. -- ChromaTan, a bioprocessing and biotools advanced biomanufacturing technology platform development company, is excited to announce an alliance with Batavia Biosciences, a leading contract development and manufacturing organization, for the development and integration of ChromaTan’s BioRMBTM continuous counter-current elution technology into Batavia’s AAV HIP-Vax® manufacturing platform. This project further highlights ChromaTan’s and Batavia’s commitment [...]
April 10, 2024
SAN DIEGO -- Parhelia Biosciences, a leader in spatial biology automation, is excited to announce the launch of the Parhelia Spatial Station at the American Association for Cancer Research Conference—a next-generation sample preparation platform designed to revolutionize spatial biology through automation and pushbutton precision. The launch of the Parhelia Spatial Station marks a critical advancement [...]
DNAnexus and Oracle Collaborate to Advance Precision Health
April 10, 2024
Mountain View, Calif. – DNAnexus, Inc., the provider of the Precision Health Data Cloud, today announced that it will collaborate with Oracle to advance precision health. This visionary endeavor is intended to drive scientific breakthroughs and improve patient outcomes globally by accelerating innovation in genomics and healthcare. This collaboration will: Focus on connecting Oracle’s and [...]
April 10, 2024
License agreement extends access to culture-stable pooled hepatocyte cell models with increased longevity for use in DMPK and ADME studies Kyiv, Ukraine, and Rennes, France -- Preci, a biotechnology company advancing patient-derived cell models to bridge the gap between preclinical testing and clinical trials, and Biopredic International, (“Biopredic”), a biotechnology company specializing in the design [...]
Metrohm Introduces OMNIS NIRS: Expanding Capabilities in Near-Infrared Spectroscopy
April 10, 2024
Metrohm is proud to announce the expansion of its OMNIS platform with the addition of near-infrared spectroscopy (NIRS) capabilities. The new OMNIS NIRS enhances the platform's versatility, enabling comprehensive chemical analysis through a single system. The introduction of OMNIS NIRS brings three specialized configurations to cater to different sample types: OMNIS NIRS Liquid for liquid [...]
Bio-Rad’s Chief Operating Officer Andrew Last to Retire
April 10, 2024
HERCULES, Calif. -- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Dr. Andrew Last, Executive Vice President and Chief Operating Officer, is planning to retire by early September of 2024. Dr. Last will remain part of Bio-Rad’s executive leadership team to ensure [...]
April 9, 2024
Innovative Hi-C-like Technique Shows Enhanced Sensitivity for Detecting Structural Variants and Chromatin Topology Features in Cancer BOSTON -- Dovetail Genomics today announces the debut of its LinkPrep™ NGS technology, showcasing its potential for de novo detection of structural variants and chromatin topology features in cancer. Through its innovative chromatin conformation approach, LinkPrep™ technology exhibits enhanced sensitivity in detecting translocations and [...]

